Clinical trials
Withdrawn Phase 3 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 2 |
| AstraZeneca | 1 |
| Chiang Mai University | 1 |
| Cordgenics, LLC | 1 |
| Health Clinics Limited | 1 |
| Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 1 |
| SOTIO a.s. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 8 |
| Fallopian Tube Neoplasms | 3 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Brenner Tumor | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Colonic Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Fatigue | 1 |
| Genital Neoplasms, Female | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.